RXI PHARMACEUTICALS CORPORATION

Company

SELLAS Life Sciences Group, Inc.

Filed

August 16, 2010

Period of Report

June 30, 2010

Accession Number

0000950123-10-078120

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →